DK1610822T3 - Flydende eller frysetørrede farmaceutiske FSH- og/eller LH-formuleringer sammen med det ikke-ioniske overfladeaktive stof poloxamer 188 og et bakteriostatisk middel - Google Patents

Flydende eller frysetørrede farmaceutiske FSH- og/eller LH-formuleringer sammen med det ikke-ioniske overfladeaktive stof poloxamer 188 og et bakteriostatisk middel

Info

Publication number
DK1610822T3
DK1610822T3 DK04725385.1T DK04725385T DK1610822T3 DK 1610822 T3 DK1610822 T3 DK 1610822T3 DK 04725385 T DK04725385 T DK 04725385T DK 1610822 T3 DK1610822 T3 DK 1610822T3
Authority
DK
Denmark
Prior art keywords
fsh
freeze
liquid
ionic surfactant
bacteriostatic agent
Prior art date
Application number
DK04725385.1T
Other languages
English (en)
Other versions
DK1610822T4 (da
Inventor
Fabrizio Samaritani
Piergiorgio Donati
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33135521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1610822(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of DK1610822T3 publication Critical patent/DK1610822T3/da
Application granted granted Critical
Publication of DK1610822T4 publication Critical patent/DK1610822T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK04725385.1T 2003-04-02 2004-04-02 Flydende farmaceutiske FSH- og LH-formuleringer sammen med et ikke-ionisk overfladeaktivt stof DK1610822T4 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03100882 2003-04-02
EP03101543 2003-05-27
EP03101828 2003-06-20
PCT/EP2004/050432 WO2004087213A1 (en) 2003-04-02 2004-04-02 Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant

Publications (2)

Publication Number Publication Date
DK1610822T3 true DK1610822T3 (da) 2011-01-31
DK1610822T4 DK1610822T4 (da) 2019-01-14

Family

ID=33135521

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04725385.1T DK1610822T4 (da) 2003-04-02 2004-04-02 Flydende farmaceutiske FSH- og LH-formuleringer sammen med et ikke-ionisk overfladeaktivt stof

Country Status (25)

Country Link
US (1) US7741268B2 (da)
EP (1) EP1610822B2 (da)
JP (1) JP4699991B2 (da)
KR (1) KR101105486B1 (da)
AR (1) AR043972A1 (da)
AT (1) ATE492292T2 (da)
AU (1) AU2004226666B9 (da)
BR (1) BRPI0409532B8 (da)
CA (1) CA2518903C (da)
CY (1) CY1111291T1 (da)
DE (1) DE602004030673D1 (da)
DK (1) DK1610822T4 (da)
EA (1) EA012565B1 (da)
HK (1) HK1086503A1 (da)
HR (1) HRP20100727T4 (da)
IL (1) IL171151A (da)
ME (1) ME00217B (da)
MX (1) MXPA05010635A (da)
NO (1) NO330214B1 (da)
NZ (1) NZ542247A (da)
PL (1) PL1610822T5 (da)
PT (1) PT1610822E (da)
RS (2) RS57872B1 (da)
SI (1) SI1610822T2 (da)
WO (1) WO2004087213A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY139088A (en) * 2005-02-21 2009-08-28 Lg Life Sciences Ltd Sustained release composition of protein drug
TWI369401B (en) * 2005-07-05 2012-08-01 Ares Trading Sa Serum-free culture medium for the production of recombinant gonadotropins
WO2007031566A1 (en) 2005-09-14 2007-03-22 Ares Trading S.A. Method for the quantitative determination of poloxamers
KR101105871B1 (ko) * 2005-09-27 2012-01-16 주식회사 엘지생명과학 인 난포자극호르몬의 안정한 용액 제형
JP5551601B2 (ja) * 2007-11-01 2014-07-16 メルク セローノ ソシエテ アノニム Ｌｈ液体調製物
PL2249869T3 (pl) 2008-02-08 2012-02-29 Theramex Hq Uk Ltd Ciekły preparat FSH
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
CN102309747B (zh) * 2008-09-17 2013-04-17 上海天伟生物制药有限公司 高纯度绝经期促性腺素冻干针剂
ES2548378T3 (es) * 2008-11-04 2015-10-16 Aska Pharmaceutical Co., Ltd. Composición acuosa que contiene hormona foliculoestimulante
EA028065B1 (ru) 2009-04-01 2017-10-31 Рациофарм Гмбх Способ очистки рекомбинантного фсг
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
KR101483165B1 (ko) 2009-12-22 2015-01-15 샹하이 테크웰 바이오파마슈티컬 컴퍼니, 리미티드 인간폐경성선자극호르몬의 조성물
WO2012127500A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for spermatogenesis
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
JP6166470B2 (ja) * 2013-11-12 2017-07-19 カディラ ヘルスケア リミティド ゴナドトロピンのための新規製剤
US9920107B2 (en) * 2014-05-23 2018-03-20 Instituto Massone S.A. Process for obtaining HMG-UP (human menopausal gonadotropin with ultra-purity grade) and a composition free of contaminants
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB839300A (en) 1957-09-05 1960-06-29 Organon Labor Ltd Adrenocorticotropic hormone preparations and process for making same
FR3819M (fr) 1963-03-11 1966-01-10 Serono Ist Farm Nouvelle hormone hypophysaire a activité différenciée.
DE3262575D1 (en) * 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US5639639A (en) * 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4589402A (en) * 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4780451B1 (en) 1987-01-23 1995-04-04 Asua International Inc Composition and method for producing superovulation in cattle
US5162306A (en) * 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
EP0318081B1 (en) * 1987-11-27 1991-07-24 Akzo N.V. Stabilization of antibodies
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5384132A (en) * 1990-03-20 1995-01-24 Akzo N.V. Stabilized gonadotropin containing preparations
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
US5374620A (en) * 1990-06-07 1994-12-20 Genentech, Inc. Growth-promoting composition and its use
DE4117078A1 (de) 1991-05-25 1992-11-26 Boehringer Ingelheim Kg Verfahren zur herstellung therapeutisch anwendbarer aerosole
US5508261A (en) * 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
ATE193540T1 (de) 1991-06-18 2000-06-15 Univ New Jersey Med Analoga von glykoproteinhormonen mit geänderter rezeptorbindungsspezifität und aktivität und verfahren zur darstellung und verwendung derselben
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5356876A (en) * 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
MD1699F2 (ro) 1992-07-31 2001-07-31 Genentech, Inc. Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei
US5661125A (en) * 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
CN1163264C (zh) * 1993-02-02 2004-08-25 爱克索马技术有限公司 改进的药物组合物
US6238890B1 (en) * 1994-02-18 2001-05-29 Washington University Single chain forms of the glycoprotein hormone quartet
US5594091A (en) 1994-02-21 1997-01-14 Takeda Chemical Industries, Ltd. Matrix for sustained-release preparation
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
PT801571E (pt) * 1994-12-22 2002-12-31 Ortho Pharma Corp Formulacoes soluveis de 2-cloro-2'-desoxiadenosina
ATE201983T1 (de) * 1995-03-10 2001-06-15 Roche Diagnostics Gmbh Polypeptid-enthaltende pharmazeutische darreichungsformen in form von mikropartikeln und verfahren zu deren herstellung
JP2758154B2 (ja) 1995-04-06 1998-05-28 エフ・ホフマン−ラ ロシユ アーゲー インターフェロンを含む液体製剤
FR2733914B1 (fr) * 1995-05-11 1997-08-01 Sanofi Sa Composition de liquide stable contenant de l'urate oxydase et composition lyophilisee pour sa preparation
AU716785B2 (en) 1995-07-27 2000-03-09 Genentech Inc. Stabile isotonic lyophilized protein formulation
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
ATE255903T1 (de) 1995-11-07 2003-12-15 Genentech Inc Stabilisierende formulierung für ngf
EP0954273A1 (en) * 1996-12-23 1999-11-10 Novo Nordisk A/S A medicament container of polymer of linear olefin for storing a liquid medicament
US6136784A (en) * 1997-01-08 2000-10-24 Amylin Pharmaceuticals, Inc. Amylin agonist pharmaceutical compositions containing insulin
EP1015493A1 (en) 1997-01-10 2000-07-05 EPIcyte Pharmaceutical, Inc. Novel epithelial tissue targeting agent
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
US20010007673A1 (en) * 1999-11-12 2001-07-12 Merrill Seymour Goldenberg Sustained-release delayed gels
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6287587B2 (en) 1997-07-15 2001-09-11 Takeda Chemical Industries, Ltd. Process for producing sustained-release preparation by in-water drying
CN1190187C (zh) 1997-10-27 2005-02-23 默克专利股份有限公司 差水溶性药物的固态溶液和分散液
MY120063A (en) 1997-12-09 2005-08-30 Lilly Co Eli Stabilized teriparatide solutions
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
US20020165146A1 (en) * 1998-07-23 2002-11-07 Hoffman James Arthur FSH article of manufacture
WO2000004913A1 (en) * 1998-07-23 2000-02-03 Eli Lilly And Company Fsh and fsh variant formulations, products and methods
FR2782455B3 (fr) * 1998-08-20 2000-09-15 Sanofi Sa Composition pharmaceutique injectable a base d'un sel pharmaceutiquement acceptable du clopidogrel ou de ticlopidine
CA2343268A1 (en) * 1998-09-17 2000-03-23 Eli Lilly And Company Protein formulations
WO2001002564A1 (fr) 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Nouveau polypeptide et adn de ce polypeptide
US6573237B2 (en) * 2001-03-16 2003-06-03 Eli Lilly And Company Protein formulations
EP1471891A4 (en) * 2002-02-08 2007-04-11 Alkermes Inc POLYMER-BASED COMPOSITIONS FOR PROLONGED RELEASE

Also Published As

Publication number Publication date
BRPI0409532B1 (pt) 2019-09-17
SI1610822T1 (sl) 2011-02-28
PT1610822E (pt) 2011-01-05
NO20054982L (no) 2005-10-26
AU2004226666B9 (en) 2010-04-08
EA200501531A1 (ru) 2006-06-30
KR101105486B1 (ko) 2012-01-13
JP4699991B2 (ja) 2011-06-15
CA2518903C (en) 2013-02-05
NZ542247A (en) 2008-03-28
WO2004087213A8 (en) 2005-03-17
EP1610822B1 (en) 2010-12-22
NO330214B1 (no) 2011-03-07
EP1610822A1 (en) 2006-01-04
RS20050737A (en) 2007-11-15
HRP20100727T1 (en) 2011-02-28
SI1610822T2 (sl) 2018-12-31
MEP31708A (en) 2010-10-10
AU2004226666B2 (en) 2009-09-03
US7741268B2 (en) 2010-06-22
CY1111291T1 (el) 2015-08-05
MXPA05010635A (es) 2005-12-12
EP1610822B2 (en) 2018-09-19
EA012565B1 (ru) 2009-10-30
US20060147480A1 (en) 2006-07-06
PL1610822T5 (pl) 2019-05-31
RS57872B1 (sr) 2018-12-31
AR043972A1 (es) 2005-08-17
JP2006522072A (ja) 2006-09-28
DE602004030673D1 (de) 2011-02-03
AU2004226666A1 (en) 2004-10-14
WO2004087213A1 (en) 2004-10-14
HRP20100727T4 (hr) 2018-11-16
KR20050110037A (ko) 2005-11-22
BRPI0409532B8 (pt) 2021-05-25
HK1086503A1 (en) 2006-09-22
CA2518903A1 (en) 2004-10-14
DK1610822T4 (da) 2019-01-14
PL1610822T3 (pl) 2011-06-30
BRPI0409532A (pt) 2006-04-18
ME00217B (me) 2011-02-10
ATE492292T2 (de) 2011-01-15
IL171151A (en) 2014-11-30

Similar Documents

Publication Publication Date Title
DK1610822T3 (da) Flydende eller frysetørrede farmaceutiske FSH- og/eller LH-formuleringer sammen med det ikke-ioniske overfladeaktive stof poloxamer 188 og et bakteriostatisk middel
DE60123274D1 (de) Pyrrolcarboxamide und pyrrolcarbothioamide und deren agrochemische verwendungen
DE60111769D1 (de) Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit
FR2891459B1 (fr) Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
FR2811761B1 (fr) Ellipsometre a haute resolution spatiale fonctionnant dans l'infrarouge
DE602005015835D1 (de) An der 4"- bzw. 4'-stellung substituiertes avermectin und avermectin-monosaccharid
DE60304993D1 (de) In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit agomelatin
EP1908779A4 (en) THYMOSINE BETA-4 DERIVATIVES AND USE THEREOF
EP1840135A4 (en) ANTI-ALPHA 9 INTEGRIN ANTIBODY AND USE THEREOF
DK1183026T3 (da) Forbedrede farmaceutiske formuleringer omfattende ritonavir
IT1319849B1 (it) Cerotto in confezione ad apertura rapida e mezzi per la realizzazionedella stessa.
NO20040702L (no) Kombinerte preparater som inneholder 1,4-benzotiepin-1,1-dioksidderivater og andre aktive substanser og anvendelsen derav
DE60038867D1 (de) Dreifache rückläufige Anzeige und deren Mechanismus
NO20033425D0 (no) Surfaktant/oksidasjonsmiddellösning og fremgangsmåter for anvendelse av samme
ITMI20001108A0 (it) Dispositivo per la movimentazione e il posizionamento di oggetti, particolarmente del tipo pannelli per la produzione di componenti d'arreda
ITRM20050319A1 (it) Apparato di telemonitoraggio e telesoccorso operante su linea gsm e relativa tecnica d'impiego.
DE60000808D1 (de) Fliessbare Pestizide Öl-in-Wasser Formulierungen
ITMI20031293A1 (it) Dispositivo di aggancio/sgancio particolarmente per telai di passeggini, carrozzine e simili.
FR2862282B1 (fr) Appareil qui se deplace dans l'air
IT1315849B1 (it) Perfezionamento nella struttura delle ruote stellate o stelle per lemacchine ranghinatrici o ranghinatori.
ES1051577Y (es) Pantalla para la visualizacion de imagenes proyectadas y/o retroproyectadas.
Brouillard Student and faculty perceptions of the causes and solutions to truancy
TH50160EX (th) ที่ปาดเนย
ITMI20022352A1 (it) Preparazioni antitumorali contenenti resveratrolo e propoli.
ITPG20050025A1 (it) Triangolo isoscele tirante sul raggio di cerchio e apotema-fumlcro antireattivo contro l'altro